HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 242 filers reported holding HORIZON PHARMA PLC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,200,000 | -1.9% | 83,225 | -27.5% | 0.01% | -14.3% |
| Q4 2018 | $2,243,000 | -14.4% | 114,802 | -14.2% | 0.01% | 0.0% |
| Q3 2018 | $2,619,000 | -9.0% | 133,754 | -23.1% | 0.01% | -22.2% |
| Q2 2018 | $2,879,000 | +9.2% | 173,877 | -6.4% | 0.02% | +5.9% |
| Q1 2018 | $2,637,000 | +40.4% | 185,684 | +44.4% | 0.02% | +41.7% |
| Q4 2017 | $1,878,000 | +15.4% | 128,606 | +0.2% | 0.01% | +9.1% |
| Q3 2017 | $1,627,000 | +25.7% | 128,348 | +17.8% | 0.01% | +37.5% |
| Q2 2017 | $1,294,000 | +5.6% | 108,994 | +31.5% | 0.01% | +14.3% |
| Q1 2017 | $1,225,000 | +171.6% | 82,883 | +197.1% | 0.01% | +250.0% |
| Q4 2016 | $451,000 | +132.5% | 27,898 | +161.3% | 0.00% | +100.0% |
| Q3 2016 | $194,000 | +10.2% | 10,677 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $176,000 | – | 10,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,609,894 | $109,460,000 | 3.84% |
| Avoro Capital Advisors LLC | 5,593,683 | $92,631,000 | 3.57% |
| Broadfin Capital, LLC | 1,339,575 | $22,183,000 | 3.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 11,912,290 | $197,268,000 | 3.45% |
| JW Asset Management, LLC | 270,775 | $4,484,000 | 2.86% |
| Rhenman & Partners Asset Management AB | 1,632,212 | $27,029,000 | 2.77% |
| Paulson & Co. | 7,670,700 | $127,027,000 | 2.60% |
| Redwood Investments, LLC | 1,315,149 | $21,779,000 | 1.50% |
| KOPP INVESTMENT ADVISORS LLC | 93,220 | $1,544,000 | 1.45% |
| 1492 Capital Management LLC | 72,951 | $1,208,000 | 0.86% |